You are here

Development of an Acoustic Biological Shaker

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 1R43GM074287-01
Agency Tracking Number: GM074287
Amount: $124,358.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: N/A
Solicitation Number: PHS2005-2
Timeline
Solicitation Year: 2005
Award Year: 2005
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
130 North Main Street
Butte, MT 59701
United States
DUNS: N/A
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 TODD MCADAMS
 (406) 723-2222
 TMCADAMS@RESODYN.COM
Business Contact
 LAWRENCE FARRAR
Phone: (406) 497-5200
Email: lcfarrar@resodyn.com
Research Institution
N/A
Abstract

DESCRIPTION (provided by applicant): This Small Business Innovation Research Phase I project will demonstrate the feasibility of using ResonantAcoustics (low-frequency acoustic mixing) as the basis for developing a highly efficient laboratory scale ResonantAcoustic Biological Shaker (RBS). Conventional biological orbital shakers have substantial drawbacks that include low oxygen transfer capability and limited applicability when scaling up to stirred-tank bioreactors. The RBS, in contrast, will provide superior mass transfer (increased oxygen transfer and reduced mixing times). During the course of project, a new type of closure will be designed in order to take full advantage of the enhanced acoustic mixing. Operating characteristics of the RBS must be optimized to maximize the growth and product expression of biological cultures. Performance of the RBS will be compared to orbital shakers for bacterial, fungal, and animal cell cultures. It is anticipated that the RBS will be able to support dramatically increased biomass levels over orbital shakers due to substantially enhanced oxygen transfer. The advantage of the RBS over conventional technology increases as culture viscosity rises, which will be especially advantageous for fungal cultures. The availability of a substantially superior laboratory shaker will have a substantial impact in increasing the pace of process development for biotechnology labs developing new Pharmaceuticals.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government